Thomas Jefferson University
Clinical trials sponsored by Thomas Jefferson University, explained in plain language.
-
New drug combo may shrink head and neck skin cancers before surgery
Disease control TerminatedThis study tests one or two immunotherapy drugs (cemiplimab alone or with fianlimab) given before surgery for people with advanced basal cell carcinoma of the head and neck. The goal is to shrink the tumor enough to allow less extensive, function-preserving surgery. About 70 adul…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 16, 2026 23:22 UTC
-
New radiation strategy aims to tackle tough brain tumors
Disease control TerminatedThis early-phase trial tests whether giving higher doses of radiation, guided by special PET/MRI scans, is safe for people with high-risk meningiomas (aggressive or recurrent brain tumors). About 24 adults will receive one of four radiation dose levels to find the highest dose th…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Liver chemo procedure shows promise for eye cancer that spread
Disease control OngoingThis study tests a procedure called chemoembolization for people with uveal melanoma (an eye cancer) that has spread to the liver. Doctors inject a chemotherapy drug (carmustine) mixed with an oily dye directly into the liver's blood supply, then block the blood flow with a spong…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Triple therapy shows promise for aggressive prostate cancer
Disease control OngoingThis early-phase study tested a combination of enzalutamide (a hormone-blocking drug), radiation therapy, and standard hormone therapy in 25 men with intermediate or high-risk prostate cancer. The main goal was to check for side effects and find the best way to give the treatment…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New drug cocktail targets Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests the safety of combining three drugs—venetoclax, lenalidomide, and rituximab—in people with follicular or marginal zone lymphoma that has returned or not responded to prior treatment. The goal is to find the best dose and see if the combination is safe…
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC
-
Biopsy needle showdown: which tool gets the best tissue sample?
Diagnosis TerminatedThis study aimed to compare two different needles used to take tissue samples from solid masses in the pancreas and digestive tract. The goal was to see which needle provides a more accurate diagnosis. The study was planned for adults needing this procedure, but it was withdrawn …
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 16, 2026 23:21 UTC
-
Smart patch could predict opioid breathing emergencies
Diagnosis ENROLLING_BY_INVITATIONThis study tests a wearable device that listens to breathing sounds to detect and predict when opioids cause dangerously slow or stopped breathing. About 120 adults recovering from surgery will wear the device, and its accuracy will be compared to standard monitors. The goal is t…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 16, 2026 12:53 UTC
-
Could a simple ultrasound replace biopsies for prostate cancer?
Diagnosis OngoingThis study tests whether a special ultrasound, using tiny gas-filled bubbles, can spot prostate cancer without a needle biopsy. About 70 men who are already scheduled for prostate removal will get this ultrasound before surgery. The goal is to see if the bubbles make cancer show …
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 15, 2026 19:01 UTC
-
New study tests better ways to ease rib fracture pain without opioids
Symptom relief OngoingThis study compares three pain relief approaches for adults aged 55 and older with rib fractures. Participants receive either a nerve block, a lidocaine infusion, or standard pain care. The goal is to see which method reduces opioid use and improves breathing.
Phase: PHASE4 • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 16, 2026 12:50 UTC
-
Earbud that zaps nerves may ease burnout in overworked doctors
Symptom relief OngoingThis study tests whether a device that gently stimulates a nerve in the ear (TAVNS) can reduce anxiety and distress in healthcare workers. About 90 participants will use the device and report their stress levels. Researchers will also use brain scans to see how the device affects…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 15, 2026 19:09 UTC
-
Antioxidant supplement may boost brain health in MS patients
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether N-acetyl cysteine (NAC), an antioxidant supplement, can improve brain function in people with multiple sclerosis (MS). Researchers will use special PET-MRI scans to measure brain activity and inflammation. About 55 adults with MS who are not planning t…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 11, 2026 12:10 UTC
-
Heart failure patients test natural supplements for better stamina
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether taking ketone or hawthorn supplements for 8 weeks can improve exercise ability and heart function in people with congestive heart failure. About 45 adults with mild to moderate heart failure will be randomly assigned to receive one of the supplements o…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 10, 2026 13:26 UTC
-
Spinal stimulation study aims to restore movement in paralyzed patients
Symptom relief TerminatedThis study tests whether electrical and magnetic stimulation can help people with chronic spinal cord injury move better and feel less stiffness. Ten participants will try different stimulation methods to see which works best. The goal is to improve walking, arm use, and daily li…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 08, 2026 13:05 UTC
-
New study aims to boost cancer screening in minority groups
Knowledge-focused TerminatedThis study looks at what helps or hinders people from getting screened for colorectal cancer, focusing on African American, Latinx, and Chinese communities. Researchers will interview and hold focus groups to understand cultural beliefs and knowledge gaps. The goal is to create a…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:22 UTC
-
Sleep study on cancer patients withdrawn before start
Knowledge-focused TerminatedThis study was designed to track sleep quality in people with head and neck cancer undergoing surgery. Researchers planned to measure factors like time to fall asleep and nighttime awakenings to understand how treatment impacts sleep. The study was withdrawn before enrolling any …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC
-
Virtual genetics board aims to improve prostate cancer care
Knowledge-focused OngoingThis study looks at how useful a web-based virtual genetics board is for doctors who treat or screen men for prostate cancer. The board helps providers discuss genetics cases, precision treatments, and screening recommendations. Researchers will interview and survey healthcare pr…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 26, 2026 12:05 UTC